European observational study on epileptic patients (Requiring at least two Antiepileptic drugs) FRESH-PEF153-en Christel LECLERC-ZWIRN European observational study on epileptic patients (Requiring at least two Antiepileptic drugs) ESPERA FRESH-PEF153-en 153 FRESH-PEF153 Christel LECLERC-ZWIRN GLAXOSMITHKLINE (FRANCE) Epidemiology France Portal (PEF) GLAXOSMITHKLINE (FRANCE) null Christel;LECLERC-ZWIRN pharmaco-resistance observational Neurology Healthcare system determinants: Use of care Healthcare system determinants To describe the population of adult patients with focal epilepsy currently being treated by an association of at least two antiepileptic medications, in terms of clinical profile, current medical management and seizure control, history of care, referral pathways and quality of life. null France Spain Individuals Patients population Male Female Young Adult (19 to 24 years) Adult (25 to 44 years) Middle Aged (45 to 64 years) Aged (65 to 79 years) Aged, 80 and over (80 years and more) • Patient aged ≥ 18 years, presenting with focal epilepsy with or without secondary generalization; • Patient currently treated with at least 2 antiepileptic medications in association, for at least 3 months, whether the patient is seizure-free or not; • Available medical data allowing to specify AEDs responsiveness status (resistant, responsive, or undefined); • Patient who has agreed to participate after having read the information letter. Clinical data Participant-reported health data Health event/morbidity Health care consumption and services Quality of life/health perception One-time cross-sectional study Probability: Stratified Through independent healthcare practitioners Through organizations (health services or institutions schools businesses etc.) [500-1000[ individuals Self-administered questionnaire Interview with the participant (including clinical) Observational Study Observational Study 800 Completed study Restricted access Access on specific project only